Navigation Links
Pioneering Safe Medication Return Initiative Reviewed During Pharmaceutical Disposal Summit
Date:6/5/2008

Capital Returns, Inc., a GENCO Supply Chain Solutions' company, to present details of the nation's first-of-its-kind safe medicine disposal pilot during U.S. Environmental Protection Agency's (Region III) Pharmaceutical

Disposal Summit in Philadelphia.

PHILADELPHIA, June 5 /PRNewswire/ -- Capital Returns, Inc. (CRI), the pharmaceutical industry's leading processor of pharmaceutical returns, today announced that attendees at the Philadelphia area regional Pharmaceutical Disposal Summit will get a first look at a consumer medication return pilot program launched last month in a two-county area in Wisconsin. Sponsored by excelleRx and U.S. EPA Region III, the summit will include environmental and pharmaceutical executives who were invited to meet today in Philadelphia to discuss the critical issues surrounding pharmaceuticals in the environment.

CRI is set to brief attendees on "Get The Meds Out," the pioneering joint effort between the University of Wisconsin, the Wisconsin Department of Natural Resources and CRI.

The pilot program involves more than 500,000 potential participants in a two-county area. Consumers in Waukesha and Winnebago counties can call a special 800 number to receive a pre-paid shipping label. CRI will handle the calls, explain the process, provide a return authorization and send out a pre-paid label for the expired or unused medications, excluding controlled substances. Once consumers receive their pre-paid labels, they package their medicines for shipment back to CRI. Packages received by CRI are processed, separated and then disposed of through incineration. The entire process is free to consumers.

A research report published by the U.S. Geological Survey, determined that pharmaceuticals have been detected in multiple waterways throughout the U.S.

As the U.S. Drug Enforcement Agency begins its attempt to modify regulations that would potentially clear the way for more national and statewide medicine take-back programs, the significance of this first-of-its-kind pilot is already being established.

"We are honored to be invited to present our solution to pharmaceutical leaders here in Philadelphia," says Mary Hendrickson, director of Quality and Regulatory Affairs for CRI. "The Get The Meds Out program is creating national attention that will only help advance consumer understanding of the issue and ease the creation of a national medication return program in the future."

About Capital Returns, Inc.

CRI is the leader in pharmaceutical trade, sample and clinical trial returns and product recalls. CRI leverages its market position to transform pharmaceutical business activities into data-rich, systematic processes that provide critical business information and value to manufacturers, pharmacies and wholesalers. Through a state-of-the-art processing facility, CRI provides comprehensive pharmaceutical returns management services to over 40 pharmaceutical manufacturers, the biggest U.S. chain pharmacies, leading wholesalers and mail order pharmacies and specialty and infusion pharmacies. For more information, visit http://www.capitalreturns.com.


'/>"/>
SOURCE GENCO
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PSI Brings its Pioneering Efforts to a Close
2. American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher
3. Boston IVF is First in Northeast to Offer Pioneering Test of Womens Biological Clock
4. Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Womens Biological Clock
5. WRAIR investigators pioneering work on an exciting new class of antimalarial compounds
6. Acclaimed A LION IN THE HOUSE Team Honored in Washington for Pioneering Work on Pediatric Cancer
7. Pioneering Heart Surgeon, Robert E. Michler, M.D., Appointed Chair of Surgery and Surgeon-in-Chief at Einstein and at Montefiore Medical Center
8. Heart stem cell scientist to honor pioneering woman scientist in keynote speech
9. Kavli Prize awarded to Pasko Rakic, pioneering Yale neuroscientist
10. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
11. Manic phase of bipolar disorder benefits from breast cancer medication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions that ... Christina Austin - CEO of Pixel Film Studios. , TransFlare 4K Mystique contains ... lens flare and light leak transitions have a very high-dynamic range for super smooth ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “The Land of ... attention to the issue of world hunger, and shares the simple and achievable answer. ... devoted husband and member of the Fairview Missionary Church in Angola, Indiana where he ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... and facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. ... of physicians and patients throughout the United States for high-quality human anti-aging ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound ... extension to RMT technology that delivers HD, dynamic, streaming ultrasound images and video ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... FRANCISCO , January 19, 2017 The global  pacemaker ... new report by Grand View Research, Inc. The heightening prevalence of cardiac conditions ... the growth of Pacemaker globally. In addition, technological enhancements in these devices are ... ... Grand View Research Logo ...
(Date:1/19/2017)... , Jan. 18, 2017 The Global Therapy ... and access to partnering deals and agreements entered into ... in partnering deals - Top deals by value - ... development, technology type The report provides understanding and ... by the world,s leading healthcare companies. The report ...
Breaking Medicine Technology: